Jonathan Go
Net Worth
Last updated:
What is Jonathan Go net worth?
The estimated net worth of Mr. Jonathan Go is at least $2,597,404 as of 12 Sep 2022. He owns shares worth $730,366 as insider, has earned $201,678 from insider trading and has received compensation worth at least $1,665,360 in iCAD, Inc..
What is the salary of Jonathan Go?
Mr. Jonathan Go salary is $416,340 per year as Chief Technology Officer in iCAD, Inc..
How old is Jonathan Go?
Mr. Jonathan Go is 62 years old, born in 1963.
What stocks does Jonathan Go currently own?
As insider, Mr. Jonathan Go owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
iCAD, Inc. (ICAD) | Chief Technology Officer | 188,725 | $3.87 | $730,366 |
What does iCAD, Inc. do?
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
Jonathan Go insider trading
iCAD, Inc.
Mr. Jonathan Go has made 3 insider trades between 2021-2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 45,000 units of ICAD stock on 12 Sep 2022. As of 12 Sep 2022 he still owns at least 188,725 units of ICAD stock.
iCAD key executives
iCAD, Inc. executives and other stock owners filed with the SEC:
- Mr. Jonathan Go (62) Chief Technology Officer
- Mr. Michael S. Klein (71) Executive Chairman & Chief Executive Officer
- Ms. Stacey M. Stevens (57) Pres